top of page

Breaking Down Boundaries, Enabling Access

Allowing early screening and diagnosis for people around the world


Southeast Asia’s pioneering surgical technology disruptor, engaged in developing innovative medical device solutions for better clinical outcomes.

Headquartered in Singapore, our unique products target unmet and underserved medical needs in hospitals and non-conventional clinical environments.

Our Products

*ENLYT® is a flexible endoscope dedicated for clinicians to screen for early signs of abnormalities.

ENLYT with R.jpg

* Soft launched at the “Promoting Healthier Connections with the World” Global Conference held at Duke University (USA).   

KLARO® is a highly versatile in vivo surgical lighting device that addresses the challenges posed by current conventional lighting modalities.

KLARO in Hand_edited.jpg

Unlock Superior Visibility

KLARO with R.png

Our Sustainability Impact


Vivo Surgical is proud to support Plastic Bank – a social enterprise dedicated to

fighting plastic pollution in the ocean.

We have committed to the annual extraction of 1,000 kg of ocean-bound plastic – equivalent to about

10,000 units of our product, KLARO™ or 50,000 plastic bottles annually.


Our Partners and Collaborators

We partner and collaborate with key leaders from healthcare systems, research institutes, government and industry, to accelerate the development of products which improve patients' quality of life. 

KKH _updated.png
NOH logo_withoutbg.png
NHIC_Corporate Logo_Full Colour.png
ESG logo.png


Vivo Surgical guarantees that our medical devices comply with all international safety and

regulatory standards.

We work closely with our development and business partners to ensure that our products and services are of the highest quality.

C-E-logo copy 2.png
iso_13485 copy.png


IP Awards 2022 Digital Badge - Winner.png
Copy of DSC_1194.JPG

Vivo Surgical has been recognised as an Award Winner in the WIPO-IPOS IP For Innovation Awards.

The WIPO-IPOS IP For Innovation Awards 2022 celebrates Singapore enterprises who have achieved outstanding growth through the successful use of intellectual property (IP).

Jointly organised by the Intellectual Property Office of Singapore (IPOS) and the World Intellectual

Property Organization (WIPO), the Awards seek to recognise IP champions who have leveraged the

effective use of IP to innovate, transform and grow their business.


Vivo Surgical has been recognised as one of the Top 4 Grand Prize Finalists in the MedTech Innovator 5th Annual Asia Pacific Competition. Over 400 companies applied to be part of the 2023 Asia Pacific Accelerator Cohort, from which 24 companies were shortlisted to partake the 4-month accelerator program.

As one of the finalists, Vivo Surgical looks forward to gaining valuable insights from the mentorship program and forging strong collaborations with industry stakeholders. 

bottom of page